This inventor holds 1 USPTO granted patent. Top assignee: Dae Hwa Pharma. Co., Ltd.. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019
Title: Jae Hoon Cheong: Innovator in Neuropsychiatric Treatments
Introduction
Jae Hoon Cheong is a notable inventor based in Gyeonggi-do, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of neuropsychiatric diseases. His innovative work has the potential to improve the quality of life for many individuals suffering from cognitive dysfunction disorders.
Latest Patents
Jae Hoon Cheong holds a patent for a pharmaceutical composition aimed at treating or preventing neuropsychiatric diseases. This composition includes flavone-6-C-glucose derivatives as active ingredients. The invention provides a functional effect in effectively treating or preventing cognitive dysfunction disorders such as delirium, dementia, amnesia, stroke, palsy, attention disorders, anxiety disorders, and sleep disorders. He has 1 patent to his name, showcasing his commitment to advancing medical science.
Career Highlights
Cheong is currently associated with Dae Hwa Pharma Co., Ltd., where he continues to develop innovative solutions in the pharmaceutical industry. His work is characterized by a strong focus on research and development, particularly in the area of neuropsychiatric health.
Collaborations
Throughout his career, Jae Hoon Cheong has collaborated with talented individuals such as Jong Hoon Ryu and Chan Young Shin. These partnerships have fostered a creative environment that encourages the development of groundbreaking treatments.
Conclusion
Jae Hoon Cheong's contributions to the field of pharmaceuticals, particularly in neuropsychiatric treatments, highlight his role as an influential inventor. His innovative patent demonstrates the potential for significant advancements in the treatment of cognitive dysfunction disorders.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile